Today's malaria control efforts are limited by our incomplete understanding of the biology of Plasmodium and of the complex relationships between human populations and the multiple species of mosquito and parasite. Research priorities include the development of in vitro culture systems for the complete life cycle of P. falciparum and P.

The civic body

The State Health Department has made it clear that the State is not under the threat of Congo fever and there is no need to panic.

The Director of Health Services convened a high-level meeting here on Thursday following the death of a Malayali in Ahmedabad, afflicted with Congo fever.

The meeting observed that the state had no threat of the fever as the fever surveillance was being carried o

The health ministry's refusal to allow the use of a highly potent mosquito control agent developed by one of its own institutes and granting permission to an imported product, has kicked up a controversy.

But With 53% Efficacy For 8 Mths, Treatment Still Inadequate For India, Say Experts
New Delhi: A malaria vaccine could be a reality by 2015.

Even as several issues of field testing of genetically modified mosquitoes to fight malaria and dengue are being debated, Oxitec, a British company founded and part-owned by the University of Oxford, carried out the world's first open field trial last year.

Indoor Residual Spraying (IRS), insecticide-treated nets (ITNs) and long-lasting insecticidal nets (LLINs) are key components in malaria prevention and control strategy. However, the development of resistance by mosquitoes to insecticides recommended for IRS and/or ITNs/LLINs would affect insecticide-based malaria vector control.

Indoor Residual Spraying (IRS), insecticide-treated nets (ITNs) and long-lasting insecticidal nets (LLINs) are key components in malaria prevention and control strategy. However, the development of resistance by mosquitoes to insecticides recommended for IRS and/or ITNs/LLINs would affect insecticide-based malaria vector control.

Australia's scientists are trying to wipe out dengue fever by a groundbreaking scheme of field trial that could save tens of thousands of lives each year, the Australian Associated Press reported on January 3.

They have developed a bacterium that acts as a vaccine for mosquitoes, which could in turn stop the disease spreading in humans, the report said.

Dr Robert D Newman tells the WHO Bulletin why malaria programmes don

Pages